Endo International PLC (NASDAQ:ENDP)
| 3.34 Delayed Data As of Jan 18 |  +0.07 / +2.14%Today’s Change | 1.94 Today|||52-Week Range 10.89 | -11.17% Year-to-Date |
Latest ENDP News | Press Releases
| Endo International (ENDP) Stock Sinks As Market Gains: What You Should Know Jan 14 / Zacks.com - Paid Partner Content | Endo International (ENDP) Dips More Than Broader Markets: What You Should Know Jan 06 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 3.27 |
| Today’s open | 3.31 |
| Day’s range | 3.18 - 3.43 |
| Volume | 4,371,923 |
| Average volume (3 months) | 8,410,012 |
| Market cap | $764.1M |
Data as of 4:01pm ET, 01/18/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -1.14% |
| Earnings growth (next 5 years) | +3.60% |
| Revenue growth (last year) | -0.39% |
| P/E ratio | 6.1 |
| Price/Sales | 0.58 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VNDAVanda Pharmaceutical... | -0.82 | -5.47% |
| ---- | ||
| KNSAKiniksa Pharmaceutic... | -0.42 | -3.71% |
| MGNXMacroGenics Inc | -1.06 | -7.34% |
Data as of 4:01pm ET, 01/18/2022
Financials
| Next reporting date | March 1, 2022 |
| EPS forecast (this quarter) | $0.64 |
| Annual revenue (last year) | $2.9B |
| Annual profit (last year) | $183.9M |
| Net profit margin | 8.52% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
